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Altered brain energetics induces 
mitochondrial fission arrest in 
Alzheimer’s Disease
Liang Zhang1,*, Sergey Trushin1,*, Trace A. Christensen2,*, Benjamin V. Bachmeier1, 
Benjamin Gateno1, Andreas Schroeder1, Jia Yao3, Kie Itoh4, Hiromi Sesaki4, Wayne W. Poon5, 
Karen H. Gylys6, Emily R. Patterson7, Joseph E. Parisi7, Roberta Diaz Brinton3,8,9, 
Jeffrey L. Salisbury2,10 & Eugenia Trushina1,10
Altered brain metabolism is associated with progression of Alzheimer’s Disease (AD). Mitochondria 
respond to bioenergetic changes by continuous fission and fusion. To account for three dimensional 
architecture of the brain tissue and organelles, we applied 3-dimensional electron microscopy (3D 
EM) reconstruction to visualize mitochondrial structure in the brain tissue from patients and mouse 
models of AD. We identified a previously unknown mitochondrial fission arrest phenotype that results 
in elongated interconnected organelles, “mitochondria-on-a-string” (MOAS). Our data suggest that 
MOAS formation may occur at the final stages of fission process and was not associated with altered 
translocation of activated dynamin related protein 1 (Drp1 ) to mitochondria but with reduced GTPase 
activity. Since MOAS formation was also observed in the brain tissue of wild-type mice in response 
to hypoxia or during chronological aging, fission arrest may represent fundamental compensatory 
adaptation to bioenergetic stress providing protection against mitophagy that may preserve residual 
mitochondrial function. The discovery of novel mitochondrial phenotype that occurs in the brain tissue 
in response to energetic stress accurately detected only using 3D EM reconstruction argues for a major 
role of mitochondrial dynamics in regulating neuronal survival.
Alzheimer’s disease (AD) is characterized by the deposition of extracellular amyloid (Aβ ) plaques, intraneuronal 
neurofibrillary tangles comprised of hyperphosphorylated tau protein (pTau), synaptic loss, and neuronal cell 
death1. Significant hypometabolic changes detected early in AD patients using 18F-fluorodeoxyglucose positron 
emission tomography suggest that abnormal energy metabolism underlies disease etiology2. Robust energy pro-
duction in neurons is essential for synaptic activity and neuronal survival. Recent studies demonstrated that energy 
production is dependent on the ability of mitochondria to undergo cycles of fission and fusion collectively termed 
“mitochondrial dynamics”3–5. Fission and fusion machinery depends on the fidelity of dynamin related protein 1 
(Drp1), mitochondrial fission factor (Mff), mitochondrial fission protein 1 (Fis1), mitofusin-1 and mitofusin-2 
(Mfn1, Mfn2), and optical atrophy 1 (Opa1) protein3,6–10. These proteins also regulate the assembly and stability 
of the respiratory chain supercomplexes inducing the remodeling of mitochondrial cristae and ultimately shaping 
mitochondrial morphology in response to the energetic demand of the cell11,12, which directly affects the develop-
ment and maintenance of synapses13. Excessive mitochondrial division has been observed in cellular and animal 
models of familial AD (FAD), and in AD patients14. Thus, understanding regional responses to changes associated 
with disease progression, particularly regarding the relationship between mitochondrial energetics and the balance 
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of mitochondrial fission and fusion, has the dual potential to elucidate basic mechanisms of disease and to sug-
gest therapeutic targets. However, most of the studies conducted to date failed to account for three-dimensional 
architecture of the brain tissue and organelles presenting critical barrier to better understanding of mitochondrial 
dynamics in AD. Here, using three-dimensional electron microscopy (3D EM) reconstruction, we identified a novel 
mitochondrial fission arrest phenotype that might represent fundamental compensatory adaptation to bioenergetic 
stress, which is relevant but not limited to AD.
Results
Extensive MOAS formation in FAD animals. Using transmission electron microscopy (TEM), we exam-
ined mitochondria in the CA1 hippocampal region from 5 transgenic mouse models carrying human FAD muta-
tions for presenilin 1 (PS1), amyloid precursor protein (APP), and mutant Tau protein (Table 1). Non-transgenic 
(NTG) littermates were used as control. Randomized blinded analysis of mitochondria in each brain tissue was 
restricted to neuropils longer than 3 μ m representing axons. We found that compared to uniformly elongated 
mitochondria in the hippocampi of NTG mice (Fig. 1a), FAD mice exhibited a broader variety of mitochondrial 
shapes ranging from ovoid (0.3 by 0.5 μ m in diameter, Fig. 1b) to teardrop profiles with tubular membrane exten-
sion(s) at one or both ends (Fig. 1c), and to teardrop shaped mitochondria (0.5 μ m in diameter) connected by thin 
double membrane extending up to 5 μ m long that we termed “mitochondria-on-a-string” (MOAS) (Fig. 1e,f). 
Fortuitous sections showed dividing mitochondria (0.3 μ m in diameter) connected by short (~100 nm) mem-
branes of uniform diameter (50–65 nm, Fig. 1d). This morphology became exaggerated in FAD animals where the 
double membrane MOAS connections varied in length and thickness, with broader connections containing mito-
chondrial matrix and cristae (Fig. 1c,g,h) and thin connections (uniformly ~65 nm in diameter) without matrix 
(Fig. 1e,f,i,j). We frequently observed apposition of MOAS and endoplasmic reticulum membranes at the junction 
between teardrop mitochondrial profiles and their connecting double membranes (Fig. 1c, inserts). MOAS were 
also observed in the brain tissue of APP/PS1 mice using super-resolution fluorescence microscopy (Fig. 1l).
The thickness of individual sections in TEM does not adequately represent the 3D architecture of mitochondria. 
This precludes critical analysis of the structure, which could predict possible functional failure. To address these 
issues, we examined mitochondrial morphology in hippocampi of FAD and NTG mice using 3D EM reconstruction 
of standard TEM images from 10–40 consecutive serial sections. We found an extensive MOAS phenotype in APP/
PS1 mice compared to uniform, tubular morphology of mitochondria in NTG mice (Fig. 2a–c, Supplementary 
Movies 1–3). When larger regions of APP/PS1 hippocampi were imaged, MOAS were pervasive throughout most 
neuropils (Fig. 2c, Supplementary Movies 2 and 3). MOAS were most prevalent in APP/PS1 and 3xTgAD mice at 
40 and 60 weeks of age reaching 50–70% (Fig. 2d) while almost no MOAS were found in age-matched NTG and 
PS1 mice at any age (Fig. 2d). MOAS were observed in ~20% of neuropils in Tau mice (Fig. 2d). These observations 
Mouse genotype Abbrev. Age, weeks Pathology/ Mitochondrial alterations Ref.
Human APP (K670N, 
M671L) under 
the control of the 
hamster prion protein 
promoter
APP 10–20; 40–60
Aβ plaques by 44 weeks; oxidative lipid damage, astrogliosis and 
microgliosis. No tangles. Impaired cognitive function at 24–40 
weeks. Reduced mitochondrial membrane potential, ATP, altered 
dynamics and hypometabolism detected before the onset of 
amyloid plaques. MOAS are observed at 10 weeks
14; 15; 41; 46; 48; 49
Human PSEN1 
(M146L) driven 
by the rat PDGF-β 
promoter
PS1 10–20; 40
No abnormal pathology up to 2.5 years. Elevated Aβ 42. Cognitive 
impairment after 48 weeks; Altered mitochondrial motility 
detected in embryonic neurons; loss of mitochondrial activity and 
altered brain energetics detected at 32 weeks. Low MOAS levels
42; 15
Human APP 
(K670N, M671L) 
crossed with PSEN1 
(M146L). The two 
trans-genes segregate 
independently
APP/PS1 10–20; 40–60
Aβ accumulation at ~24 weeks. Dystrophic neurites and 
GFAP-positive astrocytes at ~24 weeks with later microglial 
activation. Progressive cognitive impairment starting at 24 weeks.
Altered mitochondrial motility in embryonic neurons. Reduced 
mitochondrial membrane potential, ATP levels, altered dynamics 
and hypometabolism are detected before the onset of amyloid 
plaques. Substantial MOAS formation at 10 weeks
15; 43; 46
Human PSEN1 
(PS1M146V), APP 
(K670N, M671L) 
and MAPT(P30IL) 
transgenes integrated 
at a single locus 
under the control of 
the mouse Thy1.2 
promoter
3xTgAD 24; 40–60
Age-related, progressive neuropathology including plaques and 
tangles. Extracellular Aβ deposits by 24 weeks. Extensive Aβ 
deposits and Tau pathology by 48 weeks. Synaptic dysfunction, 
including LTP deficits, prior to plaques and tangles. Cognitive 
impairment by 16 weeks. Decreased mitochondrial respiration 
and pyruvate dehydrogenase protein level at 12 weeks. Increased 
hydrogen peroxide production and lipid peroxidation. Embryonic 
neurons exhibited significantly decreased mitochondrial 
respiration and increased glycolysis. MOAS formation at 24 weeks
35; 44; 47
Human Tau (P301S) 
under the direction 
of the mouse prion 
protein promoter. 
Tau 40
Neuron loss, brain atrophy and neurofibrillary tangles by 32 
weeks. Neuroinflammation with microgliosis and astrocytosis. 
Impairments in spatial memory and learning ability in Morris 
water maze. About 80 percent mortality by 12 months. Presence 
of mitochondrial dysfunction starting at 28 weeks: dysregulated 
mitochondrial enzymes; the reduction of complex V, ATP levels, 
and NADH-ubiquinone oxidoreductase activities. MOAS observed 
at 40 weeks
45; 50
Table 1. Mouse models utilized in the study. APP: amyloid precursor protein; PSEN1: presenilins 1; PDGF: 
platelet-derived growth factor; MAPT: microtubule-associated protein tau; GFAP: glial fibrillary acidic protein; 
LTP: long-term potentiation.
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suggest that MOAS represent a novel phenotype prevalent in the brain tissues of FAD and Tau mice that increases 
in frequency with disease progression and accumulated mutations.
MOAS are present in brain tissue of AD patients. We next examined whether MOAS formation is rel-
evant to human disease. We assessed hippocampal, cortical, and cerebellar postmortem tissue (fixed within 5 to 
24 hours after death, Supplementary Table S1) from cognitively normal individuals and AD patients. Consistent 
with rapid postmortem degradation, loss of tissue architecture, vacuolization of the cytoplasm and mitochon-
dria dilatation were observed in all samples examined (Fig. 3a, Supplementary Fig. S1). No differences were 
found between neuronal mitochondria in the cerebella of control and AD patients where mitochondrial profiles 
were uniformly oval (~0.5 μ m in diameter) with distinct cristae and occasional electron dense deposits (Fig. 3b). 
However, the examination of the CA1 hippocampal brain region, which is early and specifically affected in AD, 
revealed presence of teardrop mitochondria with tubular membrane extensions only in AD patients (Fig. 3a,c–e, 
Supplementary Fig. S1). These structures resembled MOAS observed in FAD mice (Fig. 1c). A MOAS phenotype 
in AD hippocampi was confirmed with serial sectioning (Fig. 3e,f). These data suggest that MOAS formation has 
relevance to a human disease condition.
Enhanced Drp1 recruitment to MOAS in FAD mice. To gain the insight into the molecular mechanism 
behind MOAS formation, we first evaluated the expression of key fission/fusion proteins in whole brain extracts 
and mitochondrial fractions from hippocampi of FAD and NTG mice (Fig. 4, Supplementary Figs S2 and S3). 
Overall expression level of Drp1, Mff, Fis1, Mfn1, Mfn2 or Opa1 in whole brain extracts from NTG and FAD 
mice was similar (Supplementary Figs S2 and S3). Likewise, no changes were noted in the abundance of the mito-
chondrial membrane protein Tom20 (Supplementary Figs S2 and S3). Thus, MOAS formation was not associated 
with a system-wide loss of fission/fusion proteins or significant changes in mitochondrial mass consistent with 
our previous observations15.
Mitochondrial fission is facilitated by phosphorylation of Drp1 at Serine position 616 (S616), which promotes 
its translocation to the mitochondria. Fission is inhibited by phosphorylation at S637, which releases Drp1 from 
mitochondria into the cytosol8. We found a significant increase in Drp1 S616 phosphorylation in whole brain 
extracts from APP/PS1 and APP mice (Fig. 4a, Supplementary Figs S2 and S3). However, no significant changes 
were detected between 3xTgAD and NTG2 animals (Fig. 4a, Supplementary Figs S2 and S3). Because whole 
brain extracts do not reflect mitochondria-associated proteins or brain regional differences, we next examined 
levels of Drp1 and its phosphorylation in enriched mitochondrial fractions isolated from the hippocampi of NTG 
Figure 1. Mitochondrial morphology in CA1 hippocampi of NTG and FAD mice visualized using standard 
TEM and super-resolution immunofluorescence. (a) Mitochondrion in a neuropil in brain tissue of a NTG 
mouse. (b–f) Micrographs of mitochondrial profiles in the brain tissue of APP (b), 3xTgAD (c,d), and APP/PS1 
(e,f) mice. (d) Consecutive serial sections of hippocampi from 3xTgAD mouse showing mitochondrial fission. 
(g–j) Membrane connections that contain mitochondrial matrix (g,h) or are devoid of matrix components (i,j) 
observed in APP/PS1 mice. (k,l) Mitochondria in brain tissue of NTG (k) or APP/PS1 (l) mice observed using 
Tom20 antibody (green) and a super-resolution fluorescence microscopy. Low magnification images on the 
right are co-stained with Hoechst (blue) to define nuclei. Scale bar, 2 μ m. Three to five mice per each genotype 
were examined. All mice were females 40 weeks of age. Ten random sections with ~100 mitochondria were 
examined by blinded investigator for each brain tissue.
www.nature.com/scientificreports/
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and 3xTgAD mice using two complementary methods, Western blot analysis and flow cytometry (Fig. 4b–d, 
Supplementary Fig. S4). We found increased levels of Drp 1 phosphorylated at S616 in the enriched mitochondrial 
fractions from 3xTgAD mice (Fig. 4b,c), which was consistent with enhanced translocation of Drp1 to mitochon-
dria detected in the whole brain extracts of APP/PS1 mice (Fig. 4a). As expected, the inactivated form of Drp1 
S637 was not readily detected in mitochondria-enriched fractions (Fig. 4b).
In agreement with the results of Western blot analysis, increased levels of Drp 1 phosphorylated at S616 
were observed on mitochondria from the 3xTgAD (53%) vs. NTG2 (19.5%) mice using flow cytometry and 
mitochondria-enriched fractions (Fig. 4d, Supplementary Fig. S4). Compared to Western blot analysis, applica-
tion of flow cytometry allows evaluating proteins specifically associated with mitochondria since the analysis is 
restricted to the organelles by setting up the precise gating parameters (Supplementary Fig. S4). Thus, increased 
S616 phosphorylation of Drp1 and its translocation to hippocampal mitochondria was observed in animals with 
most pronounced MOAS phenotype.
Hypoxia induces MOAS in WT mice. Since the recruitment and translocation of Drp1 to mitochon-
dria was enhanced in FAD hippocampi, we next examined whether formation of MOAS was associated with 
bioenergetic changes characteristic of AD brain. Along with hypometabolism, chronic hypoxia and energetic 
stress are linked to the accumulation of Aβ in brain blood vessels in AD16. We therefore investigated whether 
hypoxia-induced stress promotes MOAS formation. We exposed wild type (WT) mice to acute hypoxic condi-
tions using CO2. Age-matched WT mice euthanized by cervical dislocation without prior CO2 treatment were 
used as controls. EM evaluation revealed a pronounced formation of MOAS in ~80% of the neuropils examined 
in hippocampi of hypoxic young (10 weeks) WT mice compared to animals euthanized by cervical dislocation 
(Fig. 5a,b). Super-resolution fluorescence microscopy confirmed MOAS formation in hypoxic brain tissue of 
WT mice (Fig. 5c,d). Moreover, while Drp1 was discontinuously distributed along WT mitochondria (Fig. 5c), 
it formed rings localized to the regions of constriction along hypoxia-induced MOAS (Fig. 5d, arrows) suggest-
ing normal Drp1 recruitment but incomplete fission. Older WT animals (88 weeks) euthanized using cervical 
dislocation had increased number of MOAS compared to younger WT animals regardless of hypoxia exposure 
(Fig. 5e,f) consistent with age-related decline in brain energetics. Flow cytometry analysis of mitochondria iso-
lated from hippocampi of WT animals exposed to hypoxic conditions indicated increased size and granularity 
or internal complexity compared to control mice (Fig. 5g,h). This analysis also confirmed that formation of elon-
gated organelles in these cases was associated with enhanced recruitment of the activated Drp1 phosphorylated 
at S616 to mitochondria (Fig. 5i,j). Collectively, these observations demonstrate that energy depletion induced 
by hypoxia16 or associated with chronological aging17 rather than aberrant Drp1 recruitment may contribute to 
MOAS formation.
Figure 2. 3D EM reconstruction of mitochondria in CA1 hippocampi of NTG and APP/PS1 mice. TEM 
images from ~28 serial sections 0.09 μ m thick were stacked, aligned, and reconstructed using 3D reconstruction 
software in NTG (a) and APP/PS1 (b,c) mice 40 weeks of age (n = 3–5 per each group, all females). Scale bars, 
2 μ m. (d) Blind morphometric analysis of randomly selected EM of MOAS in CA1 brain region of FAD mice 
compared to NTG age-matched control at different ages (n = 3–9 mice per group, all females). Ten random 
sections with ~100 mitochondria were taken into analysis for each brain tissue. Data represent average ± SEM. 
NTG mice in the graph include NTG1 and NTG2 that did not have MOAS at 40 or 60 weeks of age.
www.nature.com/scientificreports/
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Inhibition of Drp1 induces MOAS formation. Since we found increased levels of activated Drp1 
recruited to mitochondria in FAD mice and demonstrated that energy deprivation induces MOAS, we hypoth-
esized that inhibition of Drp1 GTPase activity associated with energetic crisis may result in fission arrest or 
delay leading to formation of MOAS. To test this hypothesis, we investigated mitochondrial dynamics in live 
primary mouse cortical neurons using time-laps video microscopy (Fig. 6a). In WT untreated neurons, mito-
chondrial fission occurred rapidly, within ~15 seconds, following the earliest indication of MOAS formation 
(Fig. 6a Control, Supplementary Movie 4). In contrast, in neurons from FAD mice, mitochondria exhibited a 
marked fission delay (> 2 minutes) (Fig. 6a APP, Supplementary Movie 5). To determine if inhibition of Drp1 
GTPase activity is a rate-limiting step to persistence of MOAS, we treated WT neurons with physiological levels of 
15-deoxy-Δ 12,14-Prostaglandin J2 (PGJ2), a known GTPase inhibitor18, and investigated dynamics of mitochon-
drial fission. Treatment with PGJ2 did not affect mitochondrial movement, but generated persistence (> 5 min) of 
the MOAS transition state (Fig. 6a PGJ2, Supplementary Movie 6). These observations suggest that inhibition of 
Drp1 GTPase activity could contribute to fission arrest and formation of MOAS in healthy neurons.
Discussion
Using 3D EM reconstruction, we identified novel neuronal mitochondria phenotype that was present in animal 
models and in humans in response to energetic stress associated with AD, hypoxia and aging. Contrary to the 
previous reports, we did not detect excessive mitochondrial fragmentation in AD but rather observed MOAS 
phenotype that increased with disease progression and was more pronounced in animals with multiple FAD 
mutations. Mitochondrial fragmentation has been linked to the development of AD14,19 suggesting that strate-
gies designed to normalize fission/fusion machinery may attenuate disease progression. Nevertheless, most of 
the methods utilized to study mitochondrial dynamics did not take into consideration significant complexity of 
the intact brain environment with preserved 3D architecture of the tissue and mitochondria. Application of 3D 
EM reconstruction in our study clearly identified novel mitochondrial phenotype that could otherwise be easily 
mistaken for multiple fragmented organelles if examined using conventional fluorescence microscopy or TEM. 
Moreover, even with the loss of tissue integrity, we identified MOAS in the postmortem human AD brain tissues 
primarily affected in the disease.
Figure 3. MOAS phenotype in hippocampi and entorhinal cortices of AD patients. The hippocampi, 
entorhinal cortices and cerebella were collected and fixed 6 – 24 hrs postmortem. (a) Low magnification 
representative survey image of hippocampus from an AD patient illustrating the overall degree of tissue 
preservation. The box contains teardrop shaped mitochondrion with membrane extension. (b) Representative 
EM micrograph of mitochondrial profiles in cerebellum from control individual. (c,d) Representative 
micrographs of teardrop shaped mitochondria with tubular membrane extensions observed in hippocampi 
from individuals diagnosed with AD (c,d). (e,f) Serial sections demonstrating MOAS phenotype in the 
hippocampus of an AD patient. Scale bars, 0.5 μ m. Demographic data is presented in Supplementary Table S1.
www.nature.com/scientificreports/
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Mitochondrial fission is a multistep process, which includes Drp1 activation via S616 phosphorylation, Drp1 
recruitment and self-assembly on mitochondria, GTP-driven constriction of mitochondrial outer membrane 
(MOM), final scission and membrane remodeling20. Failure at any step could lead to fission arrest and formation of 
step-specific fission intermediates. Our findings indicate that MOAS formation is not associated with altered levels 
Figure 4. Activated Drp1 phosphorylated at S616 is localized to mitochondria in FAD animals. (a) Levels 
of Drp1 phosphorylated at S616 and S637 detected in the whole brain extracts from NTG1, APP, PS1, APP/
PS1, NTG2 and 3xTgAD mice using Western blot analysis. Total Drp1 was used as loading control. Each lane 
represents individual mouse with three to four mice per group (all females, 40–60 weeks of age). Blots were 
not cropped. (b) Enhanced recruitment of Drp1 and Drp1 S616 to mitochondria isolated from hippocampi of 
3xTgAD mice compared to age-matched NTG2 controls (female mice 60 weeks of age). CN – crude nuclear 
fraction; CY – cytoplasmic fraction; MT – mitochondria-enriched fraction. Heat shock protein 60 (Hsp60) 
confirmed mitochondrial enrichment and was used as loading control. Crude nuclear and cytoplasmic fractions 
were probed for nucleoporin 98 (Nu98) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Cropped 
blots are represented; full-length blots are provided in Supplementary Fig. S3. (c) Densitometry analysis of 
Drp1 S616 and total Drp1 levels in mitochondrial fractions normalized to Hsp60 levels. Experiments were 
as in (b). Data represent average ± SEM of three independent experiments. RLU – relative light units. The 
asterisk denotes p < 0.05 in a paired sample Student’s t test versus NTG. (d) Recruitment of activated Drp1 
phosphorylated at S616 to mitochondria increases in hippocampi of 3xTgAD mice compared to age-matched 
NTG2. Freshly isolated mitochondria from hippocampi (50 μ g) were stained with either Drp1 S616 or Drp1 
S637 antibodies together with Tom20 (mitochondrial marker) antibody. Mitochondria were gated based on 
light-scattering properties in the SSC and FSC modes and 20,000 events per sample were collected. To establish 
gating parameters, isotype non-specific IgG and the appropriate secondary antibodies conjugated with either 
Alexa 488 or 647 (top panels) were used. An increased phosphorylation of Drp 1 at S616 on mitochondria from 
AD (53%) vs. NTG (19.5%) animals indicates enhanced translocation (compare middle and bottom left panels). 
No changes in the level of Drp1 phosphorylated at S637 was found in mitochondrial fractions (compare middle 
and bottom right panels). Experiments were repeated three times.
www.nature.com/scientificreports/
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of expression of fission/fusion proteins or with impaired Drp1 activation, recruitment or assembly on mitochondria. 
In support of our data, the inhibition of Drp1 recruitment by PKA-mediated negative regulatory phosphorylation 
at S637/S65621, prevention of self-assembly by mdivi-1 inhibitor22 or knockout of Drp1 expression23 leads to the 
formation of long interconnected organelles but not MOAS. Moreover, we found increased localization of Drp1 
phosphorylated at S616 on mitochondria in FAD mice, which paradoxically produced MOAS rather than expected 
increase in fragmented mitochondria. In this regard, others also have shown that overexpression of mitochondrial 
Drp1 receptors MiD49/5124, expression of a dominant-negative mutant of MARCH5, a mitochondria-associated 
E3 ubiquitin ligase25 or down-regulation of F-actin regulatory proteins cortactin and cofilin26 prevented mito-
chondrial fission despite increased recruitment and proper assembly of Drp1 at scission sites. Our data suggest 
that MOAS are formed during the final steps of the fission process associated with Drp1 GTP hydrolysis and 
includes the formation of early (Fig. 1g,h) and late (Fig. 1i,j) intermediates. Examination of the width of Drp1 
assembly-constricted mitochondrial membranes on early fission intermediates revealed a consistent diameter of 
~160 nm in FAD, hypoxic and older WT mice (Fig. 5b,e,f, Supplementary Table S2). This is consistent with the 
diameter of the membranes associated with self-assembled Drp1 prior to constriction driven by GTP hydrolysis 
determined using lipid tubes (121 ± 25 nm)27 or isolated mitochondria (137 ± 60 nm)28. During GTP hydrolysis, 
Drp1-mediated fission further constricts MOMs producing final fission intermediates with membrane width 
reduced to ~80 nm28. The width of late fission intermediate membranes observed in our study falls in the same 
range: 67–94 nm in FAD and hypoxic WT mice (Supplementary Table S2). This is consistent with the hypothesis 
that MOAS represent fission intermediates formed at the GTP-driven hydrolysis constriction step before scission 
and membrane remodeling (Fig. 6b).
Analysis of the time-lapse images of mitochondrial dynamics demonstrated significant delay in fission in 
neurons from FAD mice (~15 fold) and WT neurons treated with PGJ2 (~30 fold) compared to untreated cells, 
which also supports our hypothesis that MOAS accumulation in the brain tissue of FAD mice is associated with 
the impairment of Drp1 function at the step of GTP hydrolysis. Kinetic modeling of fission where MOAS are 
considered as intermediate products of a simplified two-step reaction confirms MOAS accumulation within a few 
minutes if the efficiency of a final fission step is inhibited by 10-fold (Fig. 6b,c). Thus, our data argue that inhibition 
of Drp1 activity at the last step of fission is responsible for MOAS formation.
While we demonstrated that altered energetics, well documented in FAD mice15 and AD patients2, are sufficient 
to cause fission arrest, other mechanisms associated with AD could contribute independently or in a combination to 
MOAS formation. Thus, production of PGJ2 by activated microglia29 can reduce GTPase activity of Drp1. Indeed, 
Figure 5. Acute hypoxia induces MOAS in WT mice. (a,c) Elongated mitochondria were observed using TEM 
(a) or super-resolution fluorescence microscopy with Tom20 (red) and Drp1 (green) antibodies (c) in the CA1 
hippocampi of a WT mouse 10 weeks of age sacrificed by cervical dislocation without prior use of anesthetics. 
(b,d) Exposure of a WT mouse 10 weeks of age to CO2 for 5 min produced MOAS observed by TEM (b) or 
super-resolution fluorescence microscopy with Tom20 (red) and Drp1 (green) antibodies (d). (e) MOAS in the 
CA1 hippocampi in a WT mouse 88 weeks of age sacrificed by cervical dislocation. (f) Exposure of a WT mouse 
88 weeks of age to CO2 for 5 min caused MOAS formation. Exposure of a WT mouse 10 weeks of age to CO2 for 
5 min produced mitochondria with increased size (g, FSC histogram, median intensity of control 109.19 and 
hypoxia 203.0) and granularity (h, SSC histogram, median intensity of control 138.56 and hypoxia 268.44), and 
resulted in enhanced mitochondrial recruitment of Drp1 phosphorylated at S616 (53.8%, S616-Tom20 plots) in 
the CA1 hippocampal region compared to age-matched control. (h–j) Flow cytometry analysis of mitochondria 
isolated from hippocampi of mice exposed to hypoxic conditions compared to control mice (g,h) confirmed 
that enhanced recruitment of the activated Drp1 to mitochondria results in elongated organelles (i,j). Scale bars, 
2 μ m (a,e,b,f). Scale bars, 1 μ m (c,d). Three to four female mice per each group were examined.
www.nature.com/scientificreports/
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others have shown that incomplete fission and formation of elongated mitochondria with the width of the scission 
membranes ~91 nm was observed under conditions where GTP concentration was reduced27. GTP deficiency 
also significantly decreased the rate of Drp1 dissociation from lipid membranes upon completed fission causing 
accumulation of membrane-bound Drp127. Furthermore, MOAS formation can occur at the very last step of fission 
process, at the stage of scission and membrane remodeling. While membrane constriction driven by GTP hydrolysis 
occurs within hundreds of milliseconds, membrane remodeling associated with scission takes seconds to complete 
depending on the tension and membrane elasticity30. Membranes with high tension break within seconds31, while 
membranes with low tension require minutes32. Therefore, changes in mitochondrial membrane tension and elas-
ticity due to altered lipid composition of MOMs33 could also contribute to MOAS formation. Within our samples, 
interconnected membranes in MOAS reached up to 5 μm in length while normal fission intermediates are typically 
no longer than 100 nm. It is feasible that low tension of the MOAS membranes could arise from decreased mito-
chondrial motility observed in FAD mice15 and AD patients34. Indeed, the most substantial MOAS accumulation 
was observed in 3xTgAD and APP/PS1 mice where axonal trafficking of mitochondria is significantly inhibited15,35. 
The interconnection of altered axonal trafficking, Drp1 activity and mitochondrial dynamics is further supported 
by the observations that mitochondrial axonal motility is specifically dependent on the levels of ATP produced 
by the organelles36. Thus, negative impact on the energetics could initiate a vicious cycle affecting Drp1 activity, 
mitochondrial dynamics, motility and function ultimately contributing to AD progression. Mitochondria in the 
hippocampi of PS1 or Tau mice did not exhibit significant amount of MOAS consistent with a lesser effect of these 
mutations on trafficking, and significantly later onset of disease phenotype37.
Finally, it is interesting to speculate on functional role of MOAS. Mitochondrial fission is essential for quality 
control ensuring the removal of damaged organelles via mitophagy3. It has been shown that highly fused mitochon-
dria are formed in response to bioenergetic changes under conditions of nutrient deprivation or exposure to certain 
forms of stress38. Such rearrangement provides stress resistance and protects organelles against mitophagy39,40. 
Similar, the activity of Drp1 in 3xTgAD mice was inhibited during starvation leading to elongated mitochondria, 
which protected them from engulfment by the phagophore and subsequent degradation39,40. While the details of 
molecular mechanisms, especially with respect to the involvement of other fission/fusion proteins, remain to be 
determined, it is feasible that MOAS formation allows mitochondria to sustain cell viability during energy depri-
vation as in case of AD or hypoxia contributing residual functions towards extending a protective energetic margin 
Figure 6. MOAS formation is associated with fission delay. (a) Real-time imaging (t, seconds) of 
mitochondrial axonal movement in live cortical neurons (E17) from WT (left panel), APP mice (middle panel), 
and WT neurons treated with 2 μ M PGJ2 for 30 min prior to imaging (right panel). Arrows indicate progress 
along the axon of the same daughter mitochondrion produced after fission (asterisk) from parental organelle. 
Thirty individual mitochondria were examined from each of the three movies generated for each condition. 
Experiments were repeated in three independent platings. (b) Model of two-step reaction leading to fission 
arrest where the first step (k1) represents Drp1 recruitment to a mitochondrion and subsequent self-assembly 
resulting in formation of early fission intermediates. The second step (k2) consists of either a rapid GTP 
hydrolysis-driven constriction resulting in mitochondrial membrane scission (k2 ≫ k1) or a decrease in the 
membrane constriction/scission rate resulting in MOAS formation (k2 ≪ k1). (c) Kinetic model of MOAS 
accumulation as an intermediate product during the reaction ⇒ ⇒Mito fission intermediates Mito or MOAS2
k k1 2  
calculated as ( ) = ( (− ) − (− ))
−
MOAS t exp k t exp k tk
k k 1 2
1
2 1
 for three different scenarios. First: k2 ≪ k1 (green 
line) where = . ∗ −k 4 7 101
4 and = . ∗ −k 4 7 102
5. Second: k2 ≫ k1 (red line) where = . ∗ −k 4 7 101 4 and 
= . ∗ −k 4 7 102
3. Third: ≤k k2 1 (blue line) where = . ∗
−k 4 7 101
4 and = . ∗ −k 4 5 102
4. Fission rate of 
mitochondria in cortical neurons used for calculations for = . ∗ −k 4 7 101
4 fission/mitochondria/s−1.
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that plays a role in neuronal survival. Taken together, our study reveals greater complexity of mitochondrial fission/
fusion that includes sustained transition state dynamics. The occurrence of delayed fission during normal aging, 
hypoxia or neurodegenerative diseases provides compelling evidence for fundamental compensatory adaptation 
of mitochondria to bioenergetic stress.
Methods
Animals. The following mice were used in the study: APPSWE (K670N, M671L)41; PS1 (M146L)42; double 
transgenic APP/PS143; non-transgenic (NTG1) littermates for APP/PS1; triple transgenic mutant 3xTgAD mice44 
overexpressing PS1(M146V), APP(Swe), and tau(P301L) (animals were bred and maintained by University of 
Southern California, tissue was provided by Dr. Brinton); non-transgenic littermates (NTG2); Tau mice harbor-
ing human tau transgene with P301S mutation45 (provided by Dr. D. Baker, Mayo Clinic Rochester, MN); and 
C57B6/J (WT) mice were used in hypoxia experiments (Table 1). The animals were genotyped for the expression 
of both transgenes by a PCR method using a sample of mouse-tail DNA. The characterization of amyloid and tau 
pathologies, as well as synaptic dysfunction in 3xTgAD mice has been described previously44 and confirmed in 
Dr. Brinton’s laboratory. Mitochondrial dysfunction in FAD and Tau mice that includes reduced mitochondrial 
membrane potential and ATP levels, decreased mitochondrial dynamics and hypometabolism was described 
previously15,46—49,50. Mice were genotyped routinely to confirm the purity of the colony. Mice were housed on 
12 hours light/dark cycles and provided ad libitum access to food and water, with a regular feeding and cage-clean-
ing schedule. All procedures were performed using humane and ethical protocols approved by the Mayo Clinic 
and the University of Southern California Institutional Animal Care and Use Committees and in accordance with 
the National Institute of Health’s Guide for the Care and Use of Laboratory Animals. Three to nine animals were 
used per each group/experiment; all animals were females. Mice were matched by age and genotype, and were 
randomly assigned to the study group based on the age and genotype. The number of animals in each group was 
determined based on the 95% of chance to detect changes in 30–50% of animals. The following exclusion criteria 
were established: significant (15%) weight loss, changing in the grooming habits (hair loss), pronounced motor 
dysfunction (paralyses), or other visible signs of distress (unhealed wounds).
Human brain tissues. Experiments with post-mortem human brain tissue were approved by the Mayo 
Clinic IRB (#12-007847) and were carried out in accordance with the approved guidelines. Informed consent 
was obtained from all subjects involved in the study. Eight postmortem brain specimens from AD patients and 
age-matched control subjects were obtained from the Mayo Clinic, UCLA and the UCI Tissue Repository. All 
patients were randomly assigned to the study group based on the disease diagnosis. Demographic details on each 
subject are presented in Supplementary Table S1. Six specimens were from patients diagnosed with AD according 
to Braak criteria, and two were from age-matched control subjects. The AD brain specimens were classified from 
Braak stages I and II (early AD), III and IV (definite AD), V and VI (severe AD) or control subjects based on 
quantitative pathological features including senile plaques, neurofibrillary tangles and neuronal density. One of 
the subjects also had tauopathy with mostly tangles. The specimens from the hippocampi, entorhinal cortices and 
cerebella were immediately fixed in Trump’s solution (4% formaldehyde + 0.1% glutaraldehyde in 0.1M phos-
phate buffer) for electron microscopy processing.
Electron microscopy. EM reconstruction was done in three to five mice from each genotype (NTG1, APP, 
PS1, APP/PS1, NTG2, 3xTgAD, Tau). For TEM, mice were anesthetized with either intraperitoneal injection 
of ketamine/xylazine or inhalation of a mixture of 5% isoflurane and oxygen followed by cardio perfusion with 
4% paraformaldehyde (PFA). Whole brains were removed and post-fixed in Trump’s solution (4% formalde-
hyde + 0.1% glutaraldehyde in 0.1M phosphate buffer) overnight at room temperature. The hippocampus (CA1 
region) was dissected from each hemisphere and processed for TEM. Tissue was fixed in 1% osmium tetrox-
ide and 1% aqueous uranyl acetate, dehydrated in a graded series of ethanol, and embedded in Embed 812/
Araldite (EMS, Hatfield, PA). Thin sections (0.1 μ m) were collected on copper grids, post-stained with lead cit-
rate and viewed at 80 kV with a JEOL 1400 transmission electron microscope (JEOL USA, Peabody, MA). Ten 
random areas from each CA1 region were imaged, and only neuropils longer than 3 μ m were selected for analy-
ses. Mitochondrial profiles were scored according to their appearance as regular elongated (> 3 μ m long), ovoid 
(0.5 μ m in diameter), teardrop shaped, or MOAS. Analyses were done by investigators blinded to the mouse 
genotype.
3D EM Reconstruction
For 3D EM reconstruction, thin (0.09 μ m) serial sections (20–40 per mouse, n = 3 mice per genotype) were 
obtained from the blocks processed for conventional TEM. Serial sections were collected onto formvar coated 
slot grids (Pella, Redding CA), stained and imaged as described above. Images collected from 20–40 serial sec-
tions were then stacked, aligned, and visualized using Reconstruct software51. Reconstructions were performed on 
longitudinally sectioned neuropils that contained mitochondria.
Mitochondrial fractionation. Fresh mouse brain tissue was washed with ice-cold PBS and immersed 
in 3 mL of mitochondrial isolation buffer (MIBA) containing 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.2 M 
D-mannitol, 0.05 M sucrose, 0.5 mM sodium orthovanadate, 1 mM sodium fluoride and 1× Complete protease 
inhibitor cocktail (Roche, USA). Tissue was homogenized using a Teflon pestle, and lysis was confirmed using 
light microscopy. The crude nuclei (CN) fraction was isolated from the lysate by centrifugation at 500 × g at 4 °C 
for 5 min. The remaining supernatant was centrifuged at 8000 × g for 10 min at 4 °C yielding heavy mitochondrial 
(MT) and cytoplasmic (CY) fractions. The MT pellet was washed three times with ice-cold MIBA buffer before 
it was resuspended in 1 mL of the same buffer. To assess organelle enrichment, 20 μg of protein was separated 
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using SDS-PAGE. After transfer to PVDF, immunoblot analysis was performed using GAPDH, HSP60 and Nu98 
antibodies. Three mice from each experimental group were taken into analysis.
Flow Cytometry. Flow cytometry analysis was done using FACSCanto digital flow cytometer equipped with 
a 488-nm Argon laser and a 635-nm laser (BD Biosciences, San Jose CA); FACSDiva software (BD Biosciences) 
was used for data collection. The final data analysis was performed using the FlowJo software (FlowJo, OR). To 
exclude debris, samples were gated based on light-scattering properties in the side-scattered light (SSC) and 
forward-scattered light (FSC) modes, and 20,000 events per sample within the gate were collected. The validity 
of gating was systematically confirmed by selective mitochondrial staining with 10-N-Nonyl acridine orange 
(NAO) (100 nM, Ex/Em: 488 nm/525 nm, Life Technologies, Grand Island NY), which binds cardiolipin in the 
inner mitochondrial membrane52, with 1,1,3,3,3,3-hexamethylindodicarbocyanine iodide (DiIC1(5)) (10 nM, Ex/
Em: 633 nm/660 nm, Life Technologies) or with both stains. Briefly, 50 μ g of mitochondrial fractions were stained 
at room temperature protected from light for 15 min in 400 μ l of mitochondrial isolation MIBA buffer with 1× 
protease and 1× phosphatase inhibitors. The purity of mitochondrial fractions was consistently greater than 
95% (Supplementary Fig. S3). To measure the level of Drp1 recruitment to mitochondria, enriched hippocampal 
mitochondria (50 μ g) from either NTG2 or 3xTgAD mice were co-stained using the following antibody com-
binations: (1) Drp1 (1:50, BD Biosciences) and Tom20 (1:50, Santa Cruz Biotechnologies, Santa Cruz, CA); (2) 
Drp1 S616 (1:50, Cell Signaling, Boston, MA) and Tom 20; (3) Drp1 S637 (1:50 Cell Signaling) and Tom 20; or (4) 
isotype IgG (1:50, Thermo Scientific, Rockford, IL), which served as a staining control. The primary antibodies 
were incubated with the enriched mitochondria for 4 h in MIBA buffer at 4 °C. Secondary antibodies were labeled 
for 1 h under the same conditions following 3 washes using ice-cold MIBA buffer. Prior to FCM analysis, mito-
chondrial fractions were fixed using 4% PFA after final wash. Percent of Drp1, Drp1 S616 or Drp1 S637 localized 
on mitochondria was calculated when the particles showed double positive signals for Drp1/Tom20, Drp1 S616/
Tom20 or Drp1 S637/Tom20. All experiments were performed in duplicates; 6 mice per each genotype were used 
for FCM experiments.
Western Blot analysis. Whole brain extracts and enriched mitochondria fractions (20 μ g of protein) 
obtained as described above were subjected to the separation by SDS-PAGE followed by immunoblot analysis 
using the following antibodies: DRP1 (1:400, BD Biosciences), DRP1 S616 (1:100, Cell Signaling), DRP1 S637 
(1:100, Cell Signaling), OPA1 (1:400, BD Biosciences), HSP60 (1:200, Santa Cruz Biotechnologies), Nu98 (1:1000, 
Cell Signaling), GAPDH (1:1000, Cell Signaling), Mfn1 (1:500, Novus Biologicals, Littleton CO), Mfn2 (1:1000, 
Sigma, St Louis MO), Fis1 (1:500, Enzo Life Sciences, Farmingdale, NY), tubulin (1:5000, Sigma), MFF (1:1000, 
Abcam, San Francisco CA), and Tom20 (1:200, Santa Cruz Biotechnologies).
Hypoxia experiments. Acute hypoxia was induced in C57B6/J (WT) mice 10 and 80 weeks of age (n = 3, 
all females) by exposure to CO2 using a 4-step preprogrammed chamber that controls the flow rate over 5 min-
utes and 10 seconds: (1) 2.5 L/min of CO2 for 30 sec; (2) wait for 40 sec; (3) 10 L/min of CO2 for 60 sec; (4) wait 
for 3 min. Immediately following the CO2 exposure, mice were cardio perfused using 4% PFA; and brains were 
removed and post-fixed in Trump’s solution overnight at room temperature. Control WT mice of the same age 
and sex were euthanized by cervical dislocation (CV). The CA1 hippocampal region was dissected from each 
hemisphere and processed for TEM as described above. For flow cytometry analysis, hippocampi were isolated 
from mice without cardio perfusion and immediately placed on ice. Enriched hippocampal mitochondria were 
isolated as described above.
Immunohistochemistry. Mice were sacrificed as indicated in the corresponding figures, and brains were 
removed and fixed in 4% PFA for 2 hours at room temperature. Following cryoprotection in 30% sucrose, brains 
were embedded in optimal cutting temperature compound and coronally sectioned at 7 μ m thickness on a cry-
ostat. Slides were dried for 10 min at 37 °C, permeabilized for 5 min in − 20 °C acetone and blocked for 30 min in 
solution containing 20% normal donkey serum and 0.1% BSA in PBS. Tom20 (1:200, Santa Cruz Biotechnologies) 
and total Drp1 (1:200, BD Bioscience) were visualized using indirect immunofluorescence (Alexa647 donkey anti 
rabbit, A31573, Alexa488, donkey anti mouse, A21202, both 1:500, Life Technologies). Hoechst was used to coun-
terstain the nuclei (Hoechst 33342, Life Technologies). Sections were mounted using Prolong Gold anti-fade rea-
gent (Life Technologies). Images were acquired with Zeiss Elyra PS.1 SR-SIM equipped with an Andor iXON897 
EMCCD, alpha Plan-Apochromat 100x/1.46 Oil DIC M27 Elyra. Images were processed with Zeiss ZEN software 
black edition 2012.
Neuronal cultures and time-lapse imaging. Primary cortical neurons were cultured as we described 
previously15. For time-lapse imaging, neurons from APP mice were isolated from individual cortices of newborn 
(P1) mice; genotyping was done prior to the day of experiment. Neurons from WT mice were isolated from cor-
tices of embryonic (E17) mice. All experiments were performed in neurons cultured for 7 days unless specifically 
stated. Imaging of mitochondrial trafficking in live neurons was described previously15. Briefly, neurons were 
stained with TMRM (Molecular Probes, Eugene, OR); cells were maintained at 37 °C during imaging using confo-
cal microscope LSM 510 (Carl Zeiss Inc, Germany) with a Plan-Apochromat 100 X (1.4 na) oil objective. Six hun-
dred frames were collected in 10 min (one frame per second) and processed into a movie. The experiments were 
carried out using neurons from 3–5 independent platings. To inhibit Drp1 activity, WT neurons were treated with 
2 μ M 15-Δ -PGJ2 for 30 min prior to imaging.
Statistical Analysis. Unless specifically mentioned, data were analyzed using Student t test. P < 0.01 was 
considered statistically significant.
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